Sotyktu (deucravacitinib) - BMS
Deucravacitinib in Hidradenitis Suppurativa: An Open Label Proof of Concept Study. (PubMed, J Am Acad Dermatol) - Sep 23, 2026 - No abstract available 
Journal • Acne Vulgaris • Dermatology • Hidradenitis Suppurativa • Immunology
http://www.ncbi.nlm.nih.gov/pubmed/42772643
 
James Pham; John W Frew; Lauren Guttman; Timothy Allan
 
Sep 23, 2026
 
Prev Next